Showing results (1041-1050 of 1,273) with videos related to

Sort By:
Pageof 128
British Journal of Haematology|June 13, 2002
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphomaJonathan W Friedberg, Donna Neuberg, John G Gribben, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2013
Magnetic resonance imaging outcomes from a phase III trial of teriflunomideJerry S Wolinsky, Ponnada A Narayana, Flavia Nelson, et al.
Archives of Neurology|June 16, 2005
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statementMark S Freedman, Edward J Thompson, Florian Deisenhammer, et al.
Anti-Cancer Drugs|June 1, 1996
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, C F Verschraegen, T Levy, et al.
Lab on a Chip|February 15, 2017
Disposable cartridge platform for rapid detection of viral hemorrhagic fever virusesSteven M Scherr, David S Freedman, Krystle N Agans, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosisJ Das, J A Snowden, J Burman, et al.
Neurology|July 17, 2025
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and ProgressionMarianna Cortese, Xiaojing Peng, Gilles Edan, et al.
Frontiers in Endocrinology|April 17, 2023
ZBTB7A as a novel vulnerability in neuroendocrine prostate cancerSong Yi Bae, Hannah E Bergom, Abderrahman Day, et al.
JAMA Neurology|July 6, 2016
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD StudyLudwig Kappos, David K B Li, Olaf Stüve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndromeE D Jacobsen, H T Kim, V T Ho, et al.
Pageof 128